Nikita Shah - Mar 1, 2022 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Signature
/s/ Meredith Cook, Attorney-in-Fact
Stock symbol
AMRX
Transactions as of
Mar 1, 2022
Transactions value $
-$55,678
Form type
4
Date filed
3/3/2022, 08:21 PM
Previous filing
Mar 1, 2022
Next filing
May 10, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Options Exercise +11.7K +4.95% 249K Mar 1, 2022 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$16.1K -3.61K -1.45% $4.45 245K Mar 1, 2022 Direct F3
transaction AMRX Class A Common Stock Options Exercise +29K +11.82% 274K Mar 1, 2022 Direct F1, F2
transaction AMRX Class A Common Stock Tax liability -$39.6K -8.91K -3.25% $4.45 265K Mar 1, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMRX Restricted Stock Units Options Exercise $0 -11.7K -50% $0.00 11.7K Mar 1, 2022 Class A Common Stock 11.7K Direct F2, F4
transaction AMRX Restricted Stock Units Options Exercise $0 -29K -25% $0.00 86.9K Mar 1, 2022 Class A Common Stock 29K Direct F2, F5
transaction AMRX Restricted Stock Units Award $0 +145K $0.00 145K Mar 3, 2022 Class A Common Stock 145K Direct F2, F6
transaction AMRX Performance-Based Restricted Stock Units Award $0 +290K $0.00 290K Mar 3, 2022 Class A Common Stock 290K Direct F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the gross number of shares of common stock awarded to the reporting person in connection with the vesting of restricted stock units. The actual number of shares issued was reduced by the number of shares withheld to satisfy tax withholding obligations. See footnote 3.
F2 Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F3 Represents shares of common stock withheld to satisfy tax withholding obligations relating to the vesting of restricted stock units.
F4 On March 1, 2019, the reporting person was granted 46,914 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F5 On March 1, 2021, the reporting person was granted 115,830 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date.
F6 The restricted stock units vest in four equal annual installments beginning on March 3, 2023.
F7 Each performance-based restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F8 Represents a performance-based restricted stock unit grant of 144,928 target shares. The performance-based restricted stock units are scheduled to vest based on the Issuer's Class A Common Stock achieving certain average closing prices per share over a three-year performance period. The number of performance-based restricted stock units reported represents the maximum number of shares issuable under the award. The number that would be received upon vesting, if any, may vary from 0% to 200% of the target number. The number of performance-based restricted stock units reported in the table above represents the maximum number of shares issuable under the award. Any earned performance-based restricted stock units vest in full on February 28, 2025, the last day of the performance period.